Distinguished in Progressive External Ophthalmoplegia

Diego Martinelli

Rome, IT 
Distinguished in Progressive External Ophthalmoplegia
Rome, IT 
OverviewLocationsClinical Research

Overview

Diego Martinelli practices in Rome, Italy. Mr. Martinelli is rated as a Distinguished expert by MediFind in the treatment of Progressive External Ophthalmoplegia. His top areas of expertise are Ornithine Translocase Deficiency, Methylmalonic Acidemia with Homocystinuria, Kearns-Sayre Syndrome, Progressive External Ophthalmoplegia, and Liver Transplant.

His clinical research consists of co-authoring 142 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 10 articles in the study of Progressive External Ophthalmoplegia.

Gender
Male

Locations

Rome, Italy
Other Locations
Gesu, Italy
Mondino, Italy
Pavia, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

PEACE (Pegzilarginase Effect on Arginase 1 Deficiency Clinical Endpoints): A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Efficacy and Safety of Pegzilarginase in Children and Adults With Arginase 1 Deficiency
PEACE (Pegzilarginase Effect on Arginase 1 Deficiency Clinical Endpoints): A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Efficacy and Safety of Pegzilarginase in Children and Adults With Arginase 1 Deficiency
Enrollment Status: Completed
Publish Date: November 19, 2024
Intervention Type: Drug
Study Drug: PEG-Zilarginase
Study Phase: Phase 3
A Randomised, Controlled, Open-Label Parallel Arm Study of Safety, PK and Ammonia Control of RAVICTI® (Glycerol Phenylbutyrate) Oral Liquid and Sodium Phenylbutyrate in Phenylbutyrate Treatment Naïve Patients With Urea Cycle Disorders
A Randomised, Controlled, Open-Label Parallel Arm Study of Safety, PK and Ammonia Control of RAVICTI® (Glycerol Phenylbutyrate) Oral Liquid and Sodium Phenylbutyrate in Phenylbutyrate Treatment Naïve Patients With Urea Cycle Disorders
Enrollment Status: Completed
Publish Date: July 01, 2024
Intervention Type: Drug
Study Drugs: RAVICTI, NaPBA
Study Phase: Phase 4
View 1 Less Clinical Trial

142 Total Publications

Mitochondrial cardiomyopathies: navigating through different clinical and management pictures between adult and paediatric forms.
Mitochondrial cardiomyopathies: navigating through different clinical and management pictures between adult and paediatric forms.
Journal: Frontiers in cardiovascular medicine
Published: April 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Martinelli's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 15 Advanced Conditions
View All 63 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile